UK CFOs worry about competitiveness and rising costs, Deloitte says
UK CFOs Face Mounting Competitiveness and Cost Pressures | IMD Supply Analysis UK Financial Leaders Confront Productivity Challenges Amid Economic…
UK CFOs Face Mounting Competitiveness and Cost Pressures | IMD Supply Analysis UK Financial Leaders Confront Productivity Challenges Amid Economic…
How Fuzzy Patent Categories Drive Breakthrough Innovation and Economic Value The Power of Ambiguity in Innovation Breakthrough inventions are most…
The search for life on Mars advances as Aberystwyth University ships the Enfys infrared spectrometer for ExoMars rover testing. This critical instrument will help identify optimal drilling sites on the Martian surface for signs of past or present life.
The search for life on Mars has reached a significant milestone as Aberystwyth University ships the Enfys infrared spectrometer to Italy for integration with the ExoMars program’s Ground Test Model. This sophisticated instrument represents a crucial advancement in planetary exploration technology and marks Wales’ growing contribution to international space missions.
** Evaluating quantum computers requires looking beyond qubit counts to metrics like gate fidelity and coherence time. Understanding quantum supremacy and practical applications is key to assessing their true potential.
The journey of quantum computing has evolved dramatically from its early days, when the primary metric for a good quantum computer was simply the number of qubits. As the field has matured, researchers and manufacturers have realized that qubit quantity alone is insufficient. Today, a high-performing quantum computer balances several factors, including qubit stability, error rates, and the ability to execute complex algorithms reliably. This shift reflects a deeper understanding of what it takes to harness quantum mechanics for practical computation.
Pharmaceutical giant GSK has committed $30 billion to U.S. operations over five years, featuring advanced AI manufacturing and new biologics facilities. This massive investment will create hundreds of skilled jobs while accelerating development of next-generation medicines for respiratory diseases and cancer.
In a landmark announcement that signals significant growth for the American pharmaceutical sector, global healthcare company GSK plc has revealed plans to invest $30 billion across the United States over the next five years. This substantial commitment to research and development and manufacturing infrastructure represents one of the largest pharmaceutical investments in recent U.S. history, with advanced artificial intelligence technologies playing a central role in modernizing production facilities and accelerating drug development.
Workplace Toxicity Crisis: 80% of US Workers Report Mental Health Strain Alarming Rise in Toxic Work Environments A groundbreaking 2025…
California’s AI Crackdown: Newsom Signs Landmark Chatbot Safety Laws California Takes Lead in AI Regulation California Governor Gavin Newsom has…
China’s Deflation Deepens as Consumer Prices Fall More Than Expected Economic Pressures Mount as CPI Declines China’s consumer prices fell…
Asian investors are shrugging off renewed trade tensions between the US and China, focusing instead on Federal Reserve policy signals and key developments across technology and health sectors. Equity futures point to gains across major Asian markets as Wall Street shows resilience amid geopolitical uncertainties.
Asian markets are poised for a robust recovery in early trading sessions as investors appear to be brushing aside escalating trade tensions between the United States and China. Despite President Donald Trump’s threats to restrict cooking oil trade with China—a move that rattled Wall Street on Tuesday—market indicators across Asia suggest growing confidence in regional economic stability. This optimistic outlook comes as Federal Reserve Chair Jerome Powell signals potential interest rate cuts and an early conclusion to balance sheet reductions, creating a favorable environment for risk assets across global markets.
Samsung’s “Worlds Wide Open” event on October 21 will unveil the Galaxy XR headset, a direct rival to Apple Vision Pro. The device leverages a new Android XR platform optimized for multimodal AI experiences.
After months of speculation, Samsung has officially announced the launch date for its highly anticipated XR headset, Project Moohan, setting the stage for a direct showdown with Apple’s Vision Pro. The device, expected to be branded as the Galaxy XR, will take center stage at Samsung’s upcoming Galaxy event titled “Worlds Wide Open,” which the company promises will usher in a transformative era of multimodal AI. With reservations now open and a $100 Samsung Credit incentive, the tech giant aims to capture the burgeoning mixed reality market.